WinstonWınston
Agilon Health logo

Agilon Health

AGL
22
Medical - Care Facilities · Healthcare
Price
$129.84
+8.62 (+7.11%)
Market Cap
$2.17B
Exchange
New York Stock Exchange
Winston Score
22
Winston is worried
Weak fundamentals across most pillars.

Share count rising — dilution

+11.0% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 14.9M (2021) → 16.6M (2025)

Agilon Health helps primary care doctors take better care of elderly patients on Medicare. The company partners with physician groups across the United States and takes on the financial responsibility for managing those patients' total healthcare costs. It operates in the Medicare Advantage market, where health insurers pay a fixed amount per patient rather than per service.

Agilon makes money by receiving capitated payments — fixed monthly fees per patient — from Medicare Advantage health plans, then paying for all the medical care those patients need. It operates in multiple U.S. markets and has been growing its network of physician partners. The core idea is that keeping patients healthier costs less, which is how the company aims to eventually turn a profit. However, the company is currently losing money, with medical costs running higher than the payments it receives, and its ability to reach profitability depends heavily on improving how well it manages patient health expenses.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-7.3% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+140.0% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

29.8%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

$304M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

Agilon Health's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
4.1%
Thin — 4.1% gross margin
Operating Margin
0.7%
Thin — 0.7% operating margin
ROCE
4.8%
Weak — 4.8% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-2.8%
Shrinking sales (-2.8% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-1.3%
Burning cash (-1.3%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.17
Conservative — low debt load (0.17)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial